home / stock / rgbpp / rgbpp short
Short Information | Regen BioPharma (OTCMKTS:RGBPP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 20,293 |
Total Actual Volume | 223,626 |
Short Trends | |
---|---|
Cover Days | 9 |
Short Days | 7 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 1,015 |
Average Short Percentage | 41.94% |
Is there a RGBPP Short Squeeze or Breakout about to happen?
See the RGBPP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $0.2 | $0.25005 | $0.25005 | $0.1999 | 6,876 | 5,000 | 72.72% |
07-17-2024 | $0.16 | $0.2 | $0.25 | $0.15 | 2,598 | 512 | 19.71% |
07-11-2024 | $0.295 | $0.25 | $0.35 | $0.1651 | 65,394 | 400 | 0.61% |
07-10-2024 | $0.1651 | $0.28 | $0.5099 | $0.1651 | 48,773 | 5,668 | 11.62% |
07-09-2024 | $0.21 | $0.17 | $0.28 | $0.16 | 84,638 | 2,978 | 3.52% |
06-14-2024 | $1.0125 | $1.01 | $1.0125 | $1.01 | 444 | 40 | 9.01% |
05-24-2024 | $2.2 | $1.02 | $2.2 | $1.02 | 10,989 | 4,000 | 36.4% |
05-15-2024 | $2.8 | $2.8 | $2.8 | $2.8 | 224 | 220 | 98.21% |
05-14-2024 | $0 | $2.76 | $0 | $0 | 75 | 50 | 66.67% |
04-12-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 190 | 25 | 13.16% |
04-11-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 154 | 1 | 0.65% |
04-10-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 397 | 243 | 61.21% |
04-05-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 115 | 14 | 12.17% |
04-04-2024 | $3.2 | $3.52 | $3.52 | $3.2 | 486 | 211 | 43.42% |
04-03-2024 | $0 | $3.2 | $0 | $0 | 125 | 50 | 40% |
04-02-2024 | $2.02 | $3.2 | $3.2 | $2.02 | 834 | 150 | 17.99% |
03-22-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 982 | 400 | 40.73% |
03-18-2024 | $0 | $3.2 | $0 | $0 | 25 | 25 | 100% |
03-15-2024 | $3.2 | $3.2 | $3.2 | $3.2 | 296 | 296 | 100% |
03-14-2024 | $0 | $3.2 | $0 | $0 | 11 | 10 | 90.91% |
News, Short Squeeze, Breakout and More Instantly...
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program PR Newswire Autoimmunity to be Targeted SAN DIEGO , Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) ...